Lawrenceville, NJ, USA—May 7, 2019—ISPOR—the professional society for health economics and outcomes research, today released its 2018 Annual Report. The report highlights a very productive year with Society achieving a number of notable milestones. The Society set new records, launched many new initiatives, and reinvested heavily in its mission.
A few highlights from the Annual Report include:
The Society convened 5 global conferences and drew the largest attendance of any ISPOR conference to date at ISPOR Europe 2018 with more than 5500 attendees.
Value in Health reached a new milestone with an impact factor of 5.494. Value in Health Regional Issues is now indexed in MEDLINE/PubMed, EMBASE, Scopus, and several other scientific databases.
Dialogue With Decision
ISPOR facilitated dialogue, deliberation, and consensus building through a number of activities, including 5 Health Technology Assessment Roundtables, 5 responses to public calls for comment, 4 Patient Representatives Roundtables, publication of 3 ISPOR Reports and 7 Special Task Force Reports, and 1 Summit on value assessment and more informed healthcare pricing.
The publication of the first annual “Top 10 HEOR Trends” report was designed to inform the broader healthcare audience about the importance of health economics and outcomes research (HEOR). ISPOR also launched a number of new technology systems, including a completely redesigned website and membership platform, to better communicate and provide value to its members. The Society also refreshed its brand with a new “look and feel” that has already been recognized with a number of awards.
Investing in Our Mission:
The Society expanded its investment in mission critical initiatives with $2.9 million US in 2018 alone.
The complete 2018 ISPOR Annual Report can be downloaded here.
ISPOR CEO and Executive Director, Nancy S. Berg, stated, “Since its inception in 1995, ISPOR has continued to expand its reach and its influence in establishing international good research practices for the conduct and application of health economics and outcomes research around the world. In 2018, ISPOR set new records, launched many new initiatives, and reinvested heavily in our mission to improve healthcare decisions.”
ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Web: www.ispor.org | LinkedIn: www.linkedin.com/company/ispororg | Twitter: www.twitter.com/ispororg (@ISPORorg) | YouTube: www.youtube.com/ispororg | Facebook: www.facebook.com/ispororg | Instagram: www.instagram.com/ispororg
ABOUT VALUE IN HEALTH
Value in Health (ISSN 1098-3015) is an international, indexed journal that publishes original research and health policy articles that advance the field of health economics and outcomes research to help healthcare leaders make evidence-based decisions. The journal’s 2017 impact factor score is 5.494. Value in Health is ranked 3rd among 94 journals in healthcare sciences and services, 3rd among 79 journals in health policy and services, and 6th among 353 journals in economics. Value in Health is a monthly publication that circulates to more than 10,000 readers around the world.
Web: www.ispor.org/valueinhealth | Twitter: www.twitter.com/isporjournals (@ISPORjournals)
ABOUT VALUE IN HEALTH REGIONAL ISSUES
Value in Health Regional Issues (ISSN 2212-1099) is ISPOR’s online, MEDLINE®-indexed journal that publishes articles on health-related topics that impact the health policies and populations in the following regions: 1) Asia; 2) Central and Eastern Europe, Western Asia, and Africa; and 3) Latin America.